Zantac’s Developer
Sort by
7 items
-
Top stories - BBC News
UK firm GSK to pay $2.2bn over Zantac cancer claims
The UK-based firm has reached agreements with law firms representing about 80,000, or 93%, of claimants.4 hours ago - United Kingdom -
Sports - CBS Sports
Bears' Caleb Williams responds to DJ Moore calling him 'bossy'; Chicago GM discusses rookie QB's development
Williams knows the comment came from a good place7 hours ago - NFL -
Business - The New York Times
Zantac’s Developer Settles Lawsuits Claiming Cancer Link
GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.8 hours ago -
Business - Financial Times
GSK shares jump after drugmaker reaches $2.2bn Zantac settlement
Agreement over heartburn medicine should help to resolve concerns hanging over UK drugmaker13 hours ago -
Business - The Wall Street Journal
GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits
GSK agreed to pay more than $2 billion to settle almost all remaining liability cases in the U.S. over allegations its discontinued heartburn medicine Zantac causes cancer.14 hours ago